Haemonetics Stock Forecast - Relative Strength Index
| HAE Stock | USD 91.40 3.98 4.55% |
Haemonetics Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Haemonetics stock prices and determine the direction of Haemonetics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Haemonetics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Haemonetics |
| Check Haemonetics Volatility | Backtest Haemonetics | Information Ratio |
Haemonetics Trading Date Momentum
| On November 11 2024 Haemonetics was traded for 91.40 at the closing time. Highest Haemonetics's price during the trading hours was 91.47 and the lowest price during the day was 87.53 . The net volume was 1 M. The overall trading history on the 11th of November 2024 did not cause price change. The trading delta at closing time to current price is 4.23% . |
| Compare Haemonetics to competition |
Other Forecasting Options for Haemonetics
For every potential investor in Haemonetics, whether a beginner or expert, Haemonetics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Haemonetics Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Haemonetics. Basic forecasting techniques help filter out the noise by identifying Haemonetics' price trends.Haemonetics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Haemonetics stock to make a market-neutral strategy. Peer analysis of Haemonetics could also be used in its relative valuation, which is a method of valuing Haemonetics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Haemonetics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Haemonetics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Haemonetics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Haemonetics Market Strength Events
Market strength indicators help investors to evaluate how Haemonetics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Haemonetics shares will generate the highest return on investment. By undertsting and applying Haemonetics stock market strength indicators, traders can identify Haemonetics entry and exit signals to maximize returns.
| Accumulation Distribution | 43294.08 | |||
| Daily Balance Of Power | 1.010152 | |||
| Rate Of Daily Change | 1.05 | |||
| Day Median Price | 89.5 | |||
| Day Typical Price | 90.13 | |||
| Price Action Indicator | 3.89 | |||
| Period Momentum Indicator | 3.98 |
Haemonetics Risk Indicators
The analysis of Haemonetics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Haemonetics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting haemonetics stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.43 | |||
| Semi Deviation | 1.18 | |||
| Standard Deviation | 2.13 | |||
| Variance | 4.52 | |||
| Downside Variance | 1.99 | |||
| Semi Variance | 1.39 | |||
| Expected Short fall | (1.75) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Haemonetics is a strong investment it is important to analyze Haemonetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Haemonetics' future performance. For an informed investment choice regarding Haemonetics Stock, refer to the following important reports:Check out Historical Fundamental Analysis of Haemonetics to cross-verify your projections. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.375 | Earnings Share 2.41 | Revenue Per Share 26.77 | Quarterly Revenue Growth 0.086 | Return On Assets 0.0588 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.